Taiho Pharmaceutical Articles
Taiho Pharma files for approval of cancer drug TAS-102 in Japan
27 February 2013
Taiho to market Merck & Co’s CTLC drug vorinostat in Japan, where MSD is expelled from JPMA
17 June 2011
Otsuka gastric cancer drug Teysuno gets EU approval
16 March 2011
Showing 1-4 of 4 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
